
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Revenue | -- | $63.4M | $88.1M | $115.6M | $151.9M | |
Revenue Growth (YoY) | -- | -- | 38.92% | 31.23% | 31.4% | |
Cost of Revenues | -- | $53M | $74.8M | $94.8M | $122.1M | |
Gross Profit | -- | $10.4M | $13.3M | $20.8M | $29.8M | |
Gross Profit Margin | -- | 16.43% | 15.1% | 17.97% | 19.61% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $6.8M | $14.3M | $25.3M | $43.7M | |
Other Inc / (Exp) | -- | -$20.7K | $180.5K | -$479.4K | $43.1K | |
Operating Expenses | -- | $6.8M | $14.3M | $25.3M | $43.7M | |
Operating Income | -- | $3.6M | -$988.7K | -$4.5M | -$13.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | $3.6M | -$803.1K | -$4.8M | -$13.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $685.8K | $1.1M | $1.2M | $1.3M | |
Net Income to Company | -- | $2.9M | -$1.9M | -$6M | -$14.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | $2.9M | -$1.9M | -$6M | -$14.8M | |
Basic EPS (Cont. Ops) | -- | $0.06 | -$0.04 | -$0.12 | -$0.27 | |
Diluted EPS (Cont. Ops) | -- | $0.06 | -$0.04 | -$0.12 | -$0.27 | |
Weighted Average Basic Share | -- | $52.7M | $52.7M | $50.7M | $54.8M | |
Weighted Average Diluted Share | -- | $52.7M | $52.7M | $50.7M | $54.8M | |
EBITDA | -- | $4M | -$843.1K | -$3.4M | -$12.2M | |
EBIT | -- | $3.6M | -$988.7K | -$4.5M | -$13.9M | |
Revenue (Reported) | -- | $63.4M | $88.1M | $115.6M | $151.9M | |
Operating Income (Reported) | -- | $3.6M | -$988.7K | -$4.5M | -$13.9M | |
Operating Income (Adjusted) | -- | $3.6M | -$988.7K | -$4.5M | -$13.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $19M | $24.1M | $30M | $26.2M | |
Revenue Growth (YoY) | -- | -- | 26.94% | 24.36% | -12.74% | |
Cost of Revenues | -- | $16M | $19.6M | $23.9M | $21.4M | |
Gross Profit | -- | $3M | $4.5M | $6.1M | $4.8M | |
Gross Profit Margin | -- | 15.65% | 18.73% | 20.4% | 18.24% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $3.9M | $7.2M | $11.8M | $15.4M | |
Other Inc / (Exp) | -- | $62.9K | $592.8K | -$41.6K | -$61.9K | |
Operating Expenses | -- | $3.9M | $7.2M | $11.8M | $15.4M | |
Operating Income | -- | -$895.7K | -$2.7M | -$5.7M | -$10.6M | |
Net Interest Expenses | -- | -- | -- | -- | $32.2K | |
EBT. Incl. Unusual Items | -- | -$831.8K | -$2.1M | -$5.7M | -$10.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $158.8K | $238K | $255.5K | $177K | |
Net Income to Company | -- | -- | -$2.4M | -$5.9M | -$10.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$990.6K | -$2.3M | -$5.9M | -$10.9M | |
Basic EPS (Cont. Ops) | -- | -$0.02 | -$0.04 | -$0.11 | -$0.19 | |
Diluted EPS (Cont. Ops) | -- | -$0.02 | -$0.04 | -$0.11 | -$0.19 | |
Weighted Average Basic Share | -- | $52.7M | $53.1M | $54.3M | $57M | |
Weighted Average Diluted Share | -- | $52.7M | $53.1M | $54.3M | $57M | |
EBITDA | -- | -$825.2K | -$2.7M | -$5.3M | -$10.1M | |
EBIT | -- | -$895.7K | -$2.7M | -$5.7M | -$10.6M | |
Revenue (Reported) | -- | $19M | $24.1M | $30M | $26.2M | |
Operating Income (Reported) | -- | -$895.7K | -$2.7M | -$5.7M | -$10.6M | |
Operating Income (Adjusted) | -- | -$895.7K | -$2.7M | -$5.7M | -$10.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $104.8M | $147.2M | $144.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | $87.4M | $121.5M | $114M | |
Gross Profit | -- | -- | $17.5M | $25.7M | $30.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | $22.9M | $37.1M | $57.4M | |
Other Inc / (Exp) | -- | $62.9K | $69K | -$557.9K | -$133.3K | |
Operating Expenses | -- | -- | $22.9M | $37.1M | $57.4M | |
Operating Income | -- | -- | -$5.5M | -$11.3M | -$26.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -$5.3M | -$11.5M | -$26.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $1.3M | $1.3M | $1.3M | |
Net Income to Company | -- | -- | -- | -$12.7M | -$28M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -$6.6M | -$12.7M | -$28M | |
Basic EPS (Cont. Ops) | -- | -- | -$0.13 | -$0.23 | -$0.49 | |
Diluted EPS (Cont. Ops) | -- | -- | -$0.13 | -$0.23 | -$0.49 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -$5.2M | -$9.2M | -$24.4M | |
EBIT | -- | -- | -$5.5M | -$11.3M | -$26.7M | |
Revenue (Reported) | -- | -- | $104.8M | $147.2M | $144.7M | |
Operating Income (Reported) | -- | -- | -$5.5M | -$11.3M | -$26.6M | |
Operating Income (Adjusted) | -- | -- | -$5.5M | -$11.3M | -$26.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $19M | $83M | $114.6M | $107.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $16M | $68.5M | $95.3M | $87.2M | |
Gross Profit | -- | $3M | $14.5M | $19.2M | $20.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $3.9M | $18M | $29.7M | $43.4M | |
Other Inc / (Exp) | -- | $62.9K | $74.7K | -$3.8K | -$175.7K | |
Operating Expenses | -- | $3.9M | $18M | $29.7M | $43.4M | |
Operating Income | -- | -$895.7K | -$3.6M | -$10.5M | -$23.2M | |
Net Interest Expenses | -- | -- | -- | -- | $32.2K | |
EBT. Incl. Unusual Items | -- | -$831.8K | -$3.4M | -$10.2M | -$23.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $158.8K | $1M | $1.1M | $1.1M | |
Net Income to Company | -- | -- | -$4.5M | -$11.3M | -$24.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$990.6K | -$4.5M | -$11.3M | -$24.5M | |
Basic EPS (Cont. Ops) | -- | -$0.02 | -$0.08 | -$0.20 | -$0.43 | |
Diluted EPS (Cont. Ops) | -- | -$0.02 | -$0.08 | -$0.20 | -$0.43 | |
Weighted Average Basic Share | -- | $52.7M | $158.9M | $162.9M | $170.3M | |
Weighted Average Diluted Share | -- | $52.7M | $158.9M | $162.9M | $170.3M | |
EBITDA | -- | -$825.2K | -$3.3M | -$9.4M | -$21.7M | |
EBIT | -- | -$895.7K | -$3.6M | -$10.5M | -$23.3M | |
Revenue (Reported) | -- | $19M | $83M | $114.6M | $107.4M | |
Operating Income (Reported) | -- | -$895.7K | -$3.6M | -$10.5M | -$23.2M | |
Operating Income (Adjusted) | -- | -$895.7K | -$3.6M | -$10.5M | -$23.3M |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $85.2M | $74.5M | $40.3M | $35.1M | |
Short Term Investments | -- | -- | -- | $9.1M | -- | |
Accounts Receivable, Net | -- | $4.3M | $8.3M | $24.5M | $59.7M | |
Inventory | -- | $3.1M | $14.6M | $7.5M | $6.4M | |
Prepaid Expenses | -- | $775.1K | $65.1K | $3.2M | $912.1K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | $93.4M | $99.4M | $84.8M | $102.6M | |
Property Plant And Equipment | -- | $443.5K | $409.8K | $5.3M | $6.2M | |
Long-Term Investments | -- | -- | -- | -- | $12.2M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | $242.6K | $284.1K | |
Total Assets | -- | $93.9M | $100.7M | $90.4M | $122.6M | |
Accounts Payable | -- | $33.4M | $42.3M | $53M | $70.8M | |
Accrued Expenses | -- | $76.1K | $78.1K | $133.2K | $1.4M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | $208K | $347.5K | $837.1K | $1.2M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | $79.8M | $89M | $55.9M | $86M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $80.1M | $89M | $58.9M | $88.2M | |
Common Stock | -- | $5K | $5K | $5.4K | $5.7K | |
Other Common Equity Adj | -- | -$67.6K | -$184.7K | -$163.8K | $58.3K | |
Common Equity | -- | $13.8M | $11.8M | $31.5M | $34.5M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | $13.8M | $11.8M | $31.5M | $34.5M | |
Total Liabilities and Equity | -- | $93.9M | $100.7M | $90.4M | $122.6M | |
Cash and Short Terms | -- | $85.2M | $74.5M | $49.4M | $35.1M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | $24M | $39.5M | $23.5M | |
Short Term Investments | -- | -- | $9.6M | -- | -- | |
Accounts Receivable, Net | -- | -- | $15.4M | $47.7M | $60.4M | |
Inventory | -- | -- | $14.2M | $9.8M | $7.8M | |
Prepaid Expenses | -- | -- | -- | $1.3M | -- | |
Other Current Assets | -- | -- | $290.6K | -- | $2.2M | |
Total Current Assets | -- | -- | $63.6M | $98.7M | $94M | |
Property Plant And Equipment | -- | -- | $4.9M | $5.8M | $7.5M | |
Long-Term Investments | -- | -- | -- | $2M | $11.8M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | $72.7M | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | $215.6K | |
Total Assets | -- | -- | $142M | $108.1M | $115.7M | |
Accounts Payable | -- | -- | $56.2M | $64.7M | $81.8M | |
Accrued Expenses | -- | -- | $302.3K | $535.7K | $705.6K | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $1.1M | |
Current Portion Of Capital Lease Obligations | -- | -- | $917.3K | $1.3M | $1.7M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | -- | $58.4M | $69.7M | $96.2M | |
Long-Term Debt | -- | -- | -- | -- | $1.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $62M | $72.5M | $100.9M | |
Common Stock | -- | -- | $5K | $5.6K | $5.7K | |
Other Common Equity Adj | -- | -- | -$199.9K | $5.8K | -$26K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | $80M | $35.7M | $14.8M | |
Total Liabilities and Equity | -- | -- | $142M | $108.1M | $115.7M | |
Cash and Short Terms | -- | -- | $33.6M | $39.5M | $23.5M | |
Total Debt | -- | -- | -- | -- | $2.3M |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | $2.9M | -$1.9M | -$6M | -$14.8M | |
Depreciation & Amoritzation | -- | $320.6K | $145.5K | $1.1M | $1.7M | |
Stock-Based Compensation | -- | -- | -- | -- | $6.4M | |
Change in Accounts Receivable | -- | -$3.9M | -$4M | -$19.6M | -$41.3M | |
Change in Inventories | -- | -$3.1M | -$11.5M | $7.1M | $901.1K | |
Cash From Operations | -- | $5M | -$7.6M | -$8.5M | -$18.3M | |
Capital Expenditures | -- | $800 | $121.5K | $1M | $3.1M | |
Cash Acquisitions | -- | -- | -- | -- | -$1M | |
Cash From Investing | -- | -$800 | -$121.5K | -$10.2M | $3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$3.4M | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$283.3K | -$120.9K | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $55.5K | -$3M | -$41.9M | -$2.2M | |
Cash From Financing | -- | -$227.9K | -$3.1M | -$15.6M | $10.1M | |
Beginning Cash (CF) | -- | $80.5M | $85.2M | $74.5M | $40.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $4.8M | -$10.8M | -$34.2M | -$5.2M | |
Ending Cash (CF) | -- | $85.2M | $74.5M | $40.3M | $35.1M | |
Levered Free Cash Flow | -- | $5M | -$7.7M | -$9.5M | -$21.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$2.4M | -$5.9M | -$10.9M | |
Depreciation & Amoritzation | -- | -- | $7.2K | $380.9K | $570.7K | |
Stock-Based Compensation | -- | -- | -- | $1.8M | $1.5M | |
Change in Accounts Receivable | -- | -- | $1.5M | -$3.8M | $1.2M | |
Change in Inventories | -- | -- | $6.1M | -$2.3M | $181.1K | |
Cash From Operations | -- | -- | -$6.8M | $3.4M | -$12.5M | |
Capital Expenditures | -- | -- | $16.6K | $322.8K | -$181.8K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -$9.6M | $7.8M | -$585.5K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$3.4M | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $2.3M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -$60.5K | |
Other Financing Activities | -- | -- | -$40.5M | -$1.5M | -- | |
Cash From Financing | -- | -- | -$43.9M | $10.8M | $2.3M | |
Beginning Cash (CF) | -- | -- | $84.3M | $17.5M | $34.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -$60.2M | $22M | -$10.8M | |
Ending Cash (CF) | -- | -- | $24M | $39.5M | $23.6M | |
Levered Free Cash Flow | -- | -- | -$6.8M | $3M | -$12.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$12.7M | -$28M | |
Depreciation & Amoritzation | -- | -- | -- | $2.1M | $2.3M | |
Stock-Based Compensation | -- | -- | -- | $4.7M | $6.6M | |
Change in Accounts Receivable | -- | -- | -- | -$36.8M | -$28.8M | |
Change in Inventories | -- | -- | -- | $4.3M | $1.9M | |
Cash From Operations | -- | -- | -- | -$27M | -$13.5M | |
Capital Expenditures | -- | -- | $495.1K | $2.7M | $1.9M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | $5.9M | -$4.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$3.4M | $22K | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -$5.6M | -- | |
Cash From Financing | -- | -- | -- | $36.5M | $2.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | $15.4M | -$15.9M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -$29.7M | -$15.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$4.5M | -$11.3M | -$24.5M | |
Depreciation & Amoritzation | -- | -- | $20.9K | $1M | $1.6M | |
Stock-Based Compensation | -- | -- | -- | $4.7M | $4.9M | |
Change in Accounts Receivable | -- | -- | -$9.3M | -$26.6M | -$14.1M | |
Change in Inventories | -- | -- | $343.4K | -$2.5M | -$1.5M | |
Cash From Operations | -- | -- | $1.6M | -$16.9M | -$12.1M | |
Capital Expenditures | -- | -- | $495K | $2.2M | $922.2K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -$10.1M | $5.9M | -$1.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$3.4M | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $2.3M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -$60.5K | |
Other Financing Activities | -- | -- | -$38.6M | -$2.2M | -- | |
Cash From Financing | -- | -- | -$42M | $10.1M | $2.3M | |
Beginning Cash (CF) | -- | -- | $234.8M | $83.5M | $107.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -$50.4M | -$846.8K | -$11.5M | |
Ending Cash (CF) | -- | -- | $184.4M | $82.6M | $95.7M | |
Levered Free Cash Flow | -- | -- | $1.1M | -$19.1M | -$13M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.